Activity and Diffusion of Tigecycline (GAR-936) in Experimental Enterococcal Endocarditis

The activity of tigecycline (GAR-936), a novel glycylcycline, was investigated in vitro and in experimental endocarditis due to the susceptible Enterococcus faecalis JH2-2 strain, its VanA type transconjugant BM4316, and a clinical VanA type strain, E. faecium HB217 resistant to tetracycline. MICs o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lefort, Agnès, Lafaurie, Matthieu, Massias, Laurent, Petegnief, Yolande, Saleh-Mghir, Azzam, Muller-Serieys, Claudette, Le Guludec, Dominique, Fantin, Bruno
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2003
Schlagworte:
Experimental Therapeutics
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC148965/
https://ncbi.nlm.nih.gov/pubmed/12499194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.1.216-222.2003
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge